What Is XYL Fair Value?
Xylem Inc. (XYL) fair value estimate using multiple valuation models, updated daily.
As of August 29, 2026, Xylem Inc. (XYL) has a composite fair value estimate of $87.21 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $111.31, suggesting the stock is overvalued by 21.7%.
Data as of August 29, 2026 (today)
Composite Fair Value
Overvalued4 of 4 models$87.21
vs. current price of $111.31(-21.7%)
How Is XYL Fair Value Calculated?
Four independent models estimate what XYL is worth. Each uses different inputs and assumptions. The composite blends them by weight.
XYL Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$112.97
+1.5%Fair Value
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$39.32
-64.7%Overvalued
Inputs used
XYL Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$77.50
-30.4%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$61.66
-44.6%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $111.31 is 1.5% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $1.31B | $1.20B |
| Year 2 | $1.46B | $1.22B |
| Year 3 | $1.61B | $1.23B |
| Year 4 | $1.79B | $1.25B |
| Year 5 | $1.98B | $1.27B |
| Year 6 | $2.20B | $1.28B |
| Year 7 | $2.44B | $1.30B |
| Year 8 | $2.71B | $1.32B |
| Year 9 | $3.00B | $1.34B |
| Year 10 | $3.33B | $1.35B |
| Terminal Value | $49.32B | $20.06B |
What Are XYL's Key Financial Metrics?
Earnings & Growth
Current Price
$111.31
EPS (TTM)
$4.15
Forward P/E
17.8
Profit Margin
11.2%
Cash & Balance Sheet
Free Cash Flow
1.2B
EBITDA
2B
Book Value
$47.13
Total Debt
3.1B
What Do Analysts Say About XYL?
Low
$129.00
Average
$153.88
High
$180.00
Upside
+38.2%
XYL Fair Value FAQ
What is the fair value of XYL?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), XYL's estimated fair value is $87.21. The stock is currently trading at $111.31, which makes it overvalued by our analysis.
How is XYL's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is XYL overvalued or undervalued?
Based on our analysis, XYL is overvalued. The current price of $111.31 is 21.7% above our estimated fair value of $87.21.
What do Wall Street analysts say about XYL?
16 analysts cover Xylem Inc. with a consensus rating of "Buy." The average price target is $153.88, ranging from $129.00 to $180.00. This implies 38.2% upside from the current price.